DDD. Diallo

D. Diallo

*This is an algorithmically generated author record based on publicly available information.

D. Diallo has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

    • 1 January 2011
      • Vol. 26  (2) , 16-20

    [Study of the quality of life of hemodialysis patients at the University Hospital of Point G (CHU) in Bamako- the study of 30 cases].

    by D Diallo, S Fongoro, S Doumbia, H Maïga, C Arama

    To assess the social and psychological state development of our patients six months after their dialysis treatment. It was about a prospective study within January to June 2006. The data collection was conducted on personal search records and a questionnaire "Choice Health Experience Questionnaire" (CHEQ). The CHEQ self managed assessed the mental health, the physical health, the sexual and social functioning, the concept of sleeping disorders, familial life, leisure's and education's level. The typing was done on Epi Info 6,0 and the analyse on SPSS10. They where 20 men and 10 women or a ratio sex of 2. The average age was 40.36 years ±13.08. Twenty three patients (76.7%) were satisfied of their life in general. Four patients (13.3%) were depressed, two had sleeping disorders. Fifteen men (75%) had erection disorders. Our patients' quality of life in iterative haemodialysis remains satisfactory. A better care taking of the anaemia is necessary because it plays an important role in the erection disorders.


    • 1 January 2011
      • Vol. 26  (2) , 27-30

    [Tuberculosis in chronic hemodialysis patients at the Teaching Hospital of Point G (CHU) in Bamako].

    by S Fongoro, D Diallo, Y Toloba, S Diallo, H Maïga, C Arama

    To determine the frequency and the diagnostic difficulties of tuberculosis of haemodialysis patients. The study was about a retrospective analyse of patients haemodialysis records treated for tuberculosis within January 2003 to April 2006. The tuberculosis check-up contained a questioning, a meticulous clinic examination, thorax radiography, a tuberculosis intra dermoreaction (IDR) and the search of Koch Bacillus (BK) in biological liquids. Tuberculosis was identified to 15.52% of haemodialysis patients (10/95). The average age of our patients was from 44.3 years, with a ratio sex of 2.5 in favour of men. Tuberculosis infection happened on average 27.4 months after the beginning of the haemodialysis. We found out 50% of extra pulmonary tuberculosis (three peritoneales and two pleurales); and 50% of pulmonary tuberculosis. The IDR was positive in two cases (2/6). The search of BK didn't succeed. We reported three deaths. The effect of tuberculosis to chronic haemodialysis patients is very high. The diagnostic is sometimes difficult and is based only on specific therapeutic test.

    • 1 January 2009
      • Vol. 24  (1) , 29-32

    [Clinical and biological evolution of nephrotic syndrome patients and corticotherapy].

    by S Fongoro, D Diallo, M K Maiga

    This study was aimed to follow clinical and biological data of patients presenting a nephrotic syndrom apparently primitiv, devided in two groups. The study was prospectiv including 50 patients hospitalized from January 1999 to January 2001. The first group received prednison tablets according to their body weight, and the second group received firstly a bolus of methyl prednisone to the cumulative dose of 20mg/kg divided on 3 days; relayed by the 20mg/day of prednison tablets. The Chi2 test was estimated (p<or=0.05) The comparison of the age in the two groups was homogenous (p=0.37) and sex also (p=0.57). The ratio of these two parameters was 1.77 in favour of men. The nephrotic syndrom was pur by 38 patients (76%), and associated in 12 patients (24%). The evolution of body weight, dieresis, and proteinuria was significativ in the two groups (p<or=0.01). The blood pressure raised from 114/73 mmHg to 123/82 mmHg in the bolus group, and in the prednisone tablets group from 115/72 mmHg to 123/80 mmHg. The average hospitalisation was 5 weeks in first groups and 8 weeks in second before proteinuria disappeared in the urine. We concluted that methylprednisolon contributed to a faster normalisation of proteinuria and shorter hospitalisation time.

    • 1 January 2008
      • Vol. 23  (3) , 23-31

    [Clinical aspects, paraclinics and therapeutics of uro-genital tuberculosis].

    by A Tembély, S Fongoro, D Diallo, E Timbiné, C Arama, K Ouattara

    To specify the clinical, paraclinic and therapeutic aspects of urogenital tuberculosis in the services of Urology and Nephrology of the CHU of the Point G. From January 2005 to November 2006, six patients reached of urogenital tuberculosis were seen. The initial evaluation comprised an interrogation in the search of antecedents of urinary extra tuberculosis, a creatinemy, a urogenital echography and an intravenous urography. The research of the bacillus of Koch in the urines was made. A bacteriological examination cyto- of urines (ECBU) was carried out as well as the histological analysis of the fragment S biological and/or the part of exérèse. The incidence of urogenital tuberculosis was 0.3%. compared to the consulted patients. The principal clinical demonstrations were the lumbar pain (83.33%), the hématurie (33.33%), the pollakiurie (33.33%) and the burns mictionnell be (16.67%). 50% of the patients presented a fever and 33.33% an asthenia. Three (50%) were presented with a renal insufficiency (average creatinemy: 866.7 micromol/l). The bacilluria was present in 50% of the cases. Echography had shown anomalies in 100% of the cases of which most frequent was the urétéro hydronéphrose (2 cases, are 33.33%). The positive diagnosis was related to the bacteriological data (3 times) and histological (3 times). The treatment consisted of a bacillar anti chemotherapy among all patients in association with the surgery (4 cases) and/or of the endo-urologic operations (1 case). The diagnosis of urogenital tuberculosis remains difficult and often late in our context. A surgical or endo-urologic gesture is often necessary to preserve the renal function and to improve the quality of life.